Clinical trials
Recruiting Phase 3 Thrombosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2024 | 2 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Regeneron Pharmaceuticals | 4 |
| Ottawa Hospital Research Institute | 2 |
| Brigham and Women's Hospital | 1 |
| Fondation Hôpital Saint-Joseph | 1 |
| Queen Mary University of London | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thrombosis | 9 |
| Venous Thromboembolism | 4 |
| Atrial Fibrillation | 2 |
| Amyloid Neuropathies, Familial | 1 |
| Amyloidosis | 1 |
| Disease | 1 |
| Gastrointestinal Hemorrhage | 1 |
| Hemorrhage | 1 |
| Ischemic Stroke | 1 |
| Leg Injuries | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.